Researchers are Currently Developing “Self-Spreading” Vaccines That Can Spread From Vaccinated to Unvaccinated

Nearly a year ago, I asked the question if the experimental COVID-19 injections were “self-spreading” vaccines transmissible to unvaccinated people.

Are the Experimental COVID-19 Jabs “Self-Spreading” Vaccines Transmitting to Unvaccinated People?

I raised this question due to current research involved with these genetically-engineered vaccines.

It's a tool that's closer to reality than we think and should scare the daylights out of people who reject toxic injections.

Because "self-spreading" or "“self-disseminating” vaccines eliminate informed consent from the individual.

Self-spreading vaccines would utilize the same mechanism as transmissible diseases to move through communities.

Proponents say self-disseminating vaccines could mean they don't have to run complex mass vaccination programs. Critics say vaccines pose many health risks + would also spell the end of informed consent.

SUBSCRIBE to #TheDefender: https://t.co/zL66Edfiw5https://t.co/9w4cQfTOHe

— Robert F. Kennedy Jr (@RobertKennedyJr) June 3, 2021

Before critics scream "Fake News," let's read what Johns Hopkins stated in their 2018 “Technologies to Address Global Catastrophic Biological Risks” report:

Self-Spreading Vaccines: Self spreading vaccines are genetically engineered to move through populations like communicable diseases, but rather than causing disease, they confer protection. The vision is that a small number of individuals in a target population could be vaccinated, and the vaccine strain would then circulate in the population much like a pathogenic virus, resulting in rapid, widespread immunity.

Ingestible Bacteria for Vaccination: Bacteria can be genetically engineered to produce antigens in a human
host, acting as a vaccine, which triggers immunity to pathogens of concern. These bacteria can be placed inside capsules that are temperature stable, and they can be self-administered in the event of a pandemic.

Self-Amplifying mRNA Vaccines: SAM vaccines use the genome of a modified virus with positive sense
RNA, which is recognizable to our human translational machinery. Once delivered inside a human cell, the SAM is translated and creates 2 proteins: an antigen of interest to stimulate an immune response, and a viral replicase for intracellular amplification of the vaccine. The ability of SAM to self-replicate results in a stronger, broader, and more effective humoral and cellular immune response than some other vaccines.

Also from the report:

What is the technology?

Self-spreading vaccines—also known as transmissible or self-propagating vaccines—are genetically engineered to move through populations in the same way as communicable diseases, but rather than causing disease, they confer protection. The vision is that a small number of individuals in the target population could be vaccinated, and the
vaccine strain would then circulate in the population much like a pathogenic virus. These vaccines could dramatically increase vaccine coverage in human or animal populations without requiring each individual to be inoculated. This technology is currently aimed primarily at animal populations. Because most infectious diseases are zoonotic, 40 controlling disease in animal populations would also reduce the risk to humans. There are 2 main types of self-spreading vaccines: recombinant vector vaccines and live viral vaccines. Recombinant vector vaccines combine the elements of a pathogenic virus that induce immunity (removing the portion that causes disease) with a
transmissible viral vector. Cytomegalovirus is one candidate vector for recombinant vaccines, because it is highly species-specific and moderately transmissible. Live viral vaccines are attenuated, meaning that the vaccine viruses are much less pathogenic than wild-type and would be similar to the oral polio vaccine or the live attenuated influenza vaccine (LAIV) in that those vaccines can sometimes transmit from person to person. Although there are substantial technical challenges in genetically engineering viruses, synthetic biology tools such as CRISPR/Cas9 are likely to aid researchers in overcoming these hurdles in the coming years. Self-spreading vaccines have already been used to protect wild rabbits from myxomatosis and to control Sin Nombre virus in rodent populations. Additional work is targeting Ebola virus in apes and bats, Lassa virus in rats, and bovine tuberculosis in badgers.

Here’s a key component that I want to emphasize:

While self-spreading vaccines could help reduce illness and death in a severe pandemic, this approach comes with several big challenges. One important component of the current vaccination approach for humans is the informed consent process. In order to receive a vaccine, individuals (or their legal guardians) must be informed about the risks of vaccination by a healthcare provider and provide their consent before being vaccinated. Those who decline are not forced to receive a vaccine. In the case of self-spreading vaccines, the individuals directly vaccinated would have this option, but those to whom the vaccine subsequently spreads would not. Additionally, self-spreading vaccines would potentially infect individuals with contraindications, such as allergies, that could be life-threatening. The ethical and regulatory challenges surrounding informed consent and prevention and monitoring of adverse events would be critical challenges to implementing this approach even in an extreme event. Finally, there is a not insignificant risk of the vaccine virus reverting to wild-type virulence, as has sometimes occurred with the oral polio vaccine—which is not intended to be fully virulent or transmissible, but which has reverted to become both neurovirulent and transmissible in rare instances. This is both a medical risk and a public perception risk; the possibility of vaccine-induced disease would be a major concern to the public. Modeling efforts suggest that making self-spreading vaccines weakly transmissible might reduce the risk of reversion to wild-type virulence by limiting
the number of opportunities for the virus to evolve. However, weakly transmissible vaccines would have
to be introduced to more people to obtain sufficient immunity in the target population.

In essence, you get vaccinated from being in close proximity or making physical contact to someone who has received the injection.

The topic of self-spreading vaccines has returned to the debate stage with new developments reported by National Geographic.

Groups of scientists reportedly are developing self-spreading vaccines that could infect others from vaccinated to unvaccinated people or between vaccinated to unvaccinated animals.

The experiment was designed to spread the vaccine to unvaccinated people in vaccinated person’s close proximity.

"Researchers are currently developing self-spreading vaccines for Ebola, bovine tuberculosis, and Lassa fever, a viral disease spread by rats that causes upward of 300,000 infections annually in parts of West Africa." https://t.co/bEO5Tu1K49

— Daniel Horowitz (@RMConservative) March 23, 2022

Per National Geographic:

Advances in genomic technology and virology, and a better understanding of disease transmission, have accelerated work that began in the 1980s to make genetically engineered viruses that spread from one animal to another, imparting immunity to disease rather than infection.

Researchers are currently developing self-spreading vaccines for Ebola, bovine tuberculosis, and Lassa fever, a viral disease spread by rats that causes upward of 300,000 infections annually in parts of West Africa. The approach could be expanded to target other zoonotic diseases, including rabies, West Nile virus, Lyme disease, and the plague.

Advocates for self-spreading vaccines say they could revolutionize public health by disrupting infectious disease spread among animals before a zoonotic spillover could occur—potentially preventing the next pandemic.

Newsbreak added:

The idea is that instead of a vaccine staying in one person's body, the vaccine itself would infect them in such a way that they could pass on vaccination to others around them, much as they would otherwise pass on a disease. Scientists could vaccinate one person or animal in a community, and the vaccination would spread to those around them.

According to the report, these vaccines use a cytomegalovirus, or CMVs, a group that belongs to the herpes family.

Mayo Clinic states that once infected with the virus, your body retains the virus for life.

CMV spreads from person to person through body fluids, such as blood, saliva, urine, semen and breast milk. There is no cure, but there are medications that can help treat the symptoms.

From National Geographic:

Do You Want A Free 1oz 99.9% Pure Silver Trump Coin?

CMVs also infect a host for life, induce strong immune responses yet do not often cause severe disease. Perhaps most importantly, CMVs are uniquely species-specific; the CMV that spreads among Mastomys natalensis, the rat species that spread Lassa fever, for example, cannot infect any animals other than M. natalensis.

Several small studies have demonstrated that the CMV-based Ebola and bovine tuberculosis vaccines are effective when delivered through traditional injections. Across two trials involving about 50 monkeys, the CMV-based tuberculosis vaccine reduced disease by 68 percent, researchers reported. In a separate study, three out of four monkeys vaccinated with the Ebola vaccine survived direct exposure to Ebola.

Similar experiments with the Lassa virus vaccine are expected to start within the year, according to Redwood. That vaccine will also feature a patent-pending genetic safeguard that allows researchers to control the number of times the vaccine can multiply, thereby limiting its lifetime, Redwood explains.

So far, no one has conducted any field or laboratory studies assessing the impact and safety of these vaccines delivered via the self-spreading mechanism. However, a recent mathematical modelling study reported that if it works as expected, releasing the Lassa fever vaccine could reduce disease transmission among rodents by 95 percent in less than a year.

Like gain-of-function research, "self-spreading" vaccines consist of mad scientists acting out their God complex.

They'll start the next "pandemic" and expect more funding for their risky research.